Economic burden of HPV9-related diseases: a real-world cost analysis from Italy.
Eur J Health Econ
; 20(6): 829-840, 2019 Aug.
Article
em En
| MEDLINE
| ID: mdl-30900047
ABSTRACT
INTRODUCTION:
The objectives of this study were to estimate the economic burden of HPV in Italy, accounting for total direct medical costs associated with nine major HPV-related diseases, and to provide a measure of the burden attributable to HPV 6, 11, 16, 18, 31, 33, 45, 52, 58 infections.METHODS:
A cost-of-illness incidence-based model was developed to estimate the incidences and costs of invasive cervical cancer, cervical dysplasia, cancer of the vulva, vagina, anus, penis, oropharyngeal, anogenital warts, and recurrent respiratory papillomatosis (RRP) in the context of the Italian National Health System (NHS). We used data from hospital discharge records (HDRs) of an Italian region and conducted a systematic literature review to estimate the lifetime cost per case, the number of incident cases, the prevalence of HPV9 types. Costs of therapeutic options not included in the diagnosis-related group (DRG) tariffs were estimated through a scenario analysis.RESULTS:
In 2018, the total annual direct costs were 542.7 million, with a range of 346.7-782.0 million. These costs could increase considering innovative therapies for cancer treatment (range 16.2-37.5 million). The fraction attributable to the HPV9 genotypes without innovative cancers treatment was 329.5 million, accounting for 61% of the total annual burden of HPV-related diseases in Italy. Of this amount, 135.9 million (41%) was related to men, accounting for 64% of the costs associated with non-cervical conditions.CONCLUSIONS:
The infections by HPV9 strains and the economic burden of non-cervical HPV-related diseases in men were found to be the main drivers of direct costs.Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Doenças do Colo do Útero
/
Efeitos Psicossociais da Doença
/
Infecções por Papillomavirus
Tipo de estudo:
Health_economic_evaluation
/
Risk_factors_studies
Limite:
Female
/
Humans
País/Região como assunto:
Europa
Idioma:
En
Revista:
Eur J Health Econ
Assunto da revista:
SAUDE PUBLICA
/
SERVICOS DE SAUDE
Ano de publicação:
2019
Tipo de documento:
Article
País de afiliação:
Itália